Free Trial

Anthracite Investment Company Inc. Purchases New Stake in Bath & Body Works, Inc. (NYSE:BBWI)

Bath & Body Works logo with Retail/Wholesale background

Anthracite Investment Company Inc. purchased a new position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 91,500 shares of the company's stock, valued at approximately $2,921,000. Bath & Body Works accounts for approximately 1.3% of Anthracite Investment Company Inc.'s investment portfolio, making the stock its 29th largest position.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Janney Montgomery Scott LLC purchased a new stake in Bath & Body Works during the first quarter worth about $203,000. Vanguard Group Inc. boosted its stake in Bath & Body Works by 4.2% in the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company's stock worth $1,370,458,000 after buying an additional 1,102,124 shares in the last quarter. O Shaughnessy Asset Management LLC raised its holdings in Bath & Body Works by 3.4% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 17,626 shares of the company's stock valued at $882,000 after buying an additional 578 shares during the last quarter. UniSuper Management Pty Ltd boosted its holdings in shares of Bath & Body Works by 576.9% during the first quarter. UniSuper Management Pty Ltd now owns 22,799 shares of the company's stock worth $1,140,000 after purchasing an additional 19,431 shares during the period. Finally, Natixis raised its stake in Bath & Body Works by 47.3% in the first quarter. Natixis now owns 19,446 shares of the company's stock worth $973,000 after buying an additional 6,245 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Gina Boswell acquired 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company's stock, valued at $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is owned by insiders.

Analysts Set New Price Targets

BBWI has been the subject of several recent analyst reports. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $42.00 price target on shares of Bath & Body Works in a research report on Monday. UBS Group reduced their target price on Bath & Body Works from $52.00 to $38.00 and set a "neutral" rating on the stock in a report on Thursday, August 29th. Citigroup cut their price objective on shares of Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 20th. Wells Fargo & Company reduced their target price on shares of Bath & Body Works from $35.00 to $32.00 and set an "equal weight" rating for the company in a report on Wednesday, November 6th. Finally, Evercore ISI reduced their target price on Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating for the company in a research note on Wednesday, August 28th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of "Moderate Buy" and an average price target of $42.44.

Read Our Latest Stock Analysis on Bath & Body Works

Bath & Body Works Trading Up 0.3 %

BBWI stock traded up $0.08 during mid-day trading on Wednesday, reaching $30.52. The company's stock had a trading volume of 4,068,720 shares, compared to its average volume of 3,829,920. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The stock has a market cap of $6.69 billion, a PE ratio of 7.37, a P/E/G ratio of 1.00 and a beta of 1.79. The company's 50 day moving average is $30.34 and its two-hundred day moving average is $36.18.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.02. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. On average, analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date is Friday, November 22nd. Bath & Body Works's dividend payout ratio (DPR) is 19.37%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured Articles

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Should you invest $1,000 in Bath & Body Works right now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines